miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance.

Tavakoli Pirzaman A, Ebrahimi P, Hasanpour AH, Shakeri M, Babajani B, Pourali Ganji Z, Babaei H, Rahmati A, Hosseinzadeh R, Doostmohamadian S, Kazemi S

Open source

DOI
10.1177/15330338231202391
Published
2023 Jan-Dec
Container
Technology in cancer research & treatment
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/15330338231202391,
  title = {miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance.},
  author = {Tavakoli Pirzaman A and Ebrahimi P and Hasanpour AH and Shakeri M and Babajani B and Pourali Ganji Z and Babaei H and Rahmati A and Hosseinzadeh R and Doostmohamadian S and Kazemi S},
  year = {2023},
  journal = {Technology in cancer research \& treatment},
  doi = {10.1177/15330338231202391},
  url = {https://doi.org/10.1177/15330338231202391}
}

RIS

TY  - JOUR
TI  - miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance.
AU  - Tavakoli Pirzaman A
AU  - Ebrahimi P
AU  - Hasanpour AH
AU  - Shakeri M
AU  - Babajani B
AU  - Pourali Ganji Z
AU  - Babaei H
AU  - Rahmati A
AU  - Hosseinzadeh R
AU  - Doostmohamadian S
AU  - Kazemi S
PY  - 2023
JO  - Technology in cancer research & treatment
DO  - 10.1177/15330338231202391
UR  - https://doi.org/10.1177/15330338231202391
ER  - 

APA

A, T. P., P, E., AH, H., M, S., B, B., Z, P. G., H, B., A, R., R, H., S, D., & S, K. (2023). miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance.. Technology in cancer research & treatment. https://doi.org/10.1177/15330338231202391

Source records